Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
George Whitesides
AddedMar 31, 2024
UpdatedJun 28, 2026
George Whitesides

George Whitesides

Founder, Theravance Biopharma

Crunchbase

George Whitesides's Career

Theravance Biopharma
Theravance Biopharma

South San Francisco, CA, US

Founder
Lyra Therapeutics
Lyra Therapeutics

Watertown, MA, US

Co-Founder
GelTex Pharmaceuticals
GelTex Pharmaceuticals

Waltham, MA, US

Co-Founder
Nano Terra
Nano Terra

Cambridge, MA, US

Board Member· Board
Soft Robotics
Soft Robotics

Cambridge, MA, US

Board Member· Board
MC10
MC10

Cambridge, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

George Whitesides's Career

Theravance Biopharma
Theravance Biopharma
Public$663.2M1111996South San Francisco, CA, US
Founder

Leadership at Theravance Biopharma

Rick E WinninghamRick E WinninghamBoard Member
Eran BroshyEran BroshyBoard Member
Bob GundersonBob GundersonBoard Member
Bill YoungBill YoungBoard Member
Burton Gordon MalkielBurton Gordon MalkielBoard Member

Similar to Theravance Biopharma

Therabron TherapeuticsTherabron TherapeuticsRockville, MD, USProprietary Drugsest. 2007Therabron TherapeuticsRockville, MD, US · est. 2007

Therabron Therapeutics Inc.: A biopharmaceutical firm creating proprietary drugs for specific conditions.

Public · $17.9M30
PTC TherapeuticsPTC TherapeuticsSouth Plainfield, NJ, USPharmaceuticalsest. 1998PTC TherapeuticsSouth Plainfield, NJ, US · est. 1998

PTC Therapeutics, Inc.: A US-based pharmaceutical company specializing in oral, small-molecule drugs for genetic disorders, oncology, and infectious diseases.

Public · $1.6B1.4k
Theron PharmaceuticalsTheron PharmaceuticalsSunnyvale, CA, USPharmaceuticalsest. 2008Theron PharmaceuticalsSunnyvale, CA, US · est. 2008

Theron Pharmaceuticals, a US-based biotech firm, develops long-acting treatments for chronic respiratory diseases.

Angel · $2.2M7
MediciNovaMediciNovaLos Angeles, CA, USTherapeuticsest. 2000MediciNovaLos Angeles, CA, US · est. 2000

US-based MediciNova develops small molecule therapeutics for various diseases, focusing on the US market.

Public · $136M13
Lyra Therapeutics
Lyra Therapeutics
Public$264.1M662014Watertown, MA, US
Co-Founder

Leadership at Lyra Therapeutics

Guido NeelsGuido NeelsBoard Member
Nancy SnydermanNancy SnydermanBoard Member
Paulina HillPaulina HillBoard Member
Bob LangerBob LangerBoard Member
Terry McguireTerry McguireBoard Member
Konstantin PoukalovKonstantin PoukalovBoard Member

Similar to Lyra Therapeutics

LyndraLyndraWatertown, MA, USPharmaceuticals, Therapiesest. 2015LyndraWatertown, MA, US · est. 2015

US-based Lyndra Therapeutics develops therapies for Alzheimer's, HIV, opioid use disorder, and schizophrenia.

Series E · $284.6M161
Lyric PharmaceuticalsLyric PharmaceuticalsSan Francisco, CA, USTherapeuticsest. 2013Lyric PharmaceuticalsSan Francisco, CA, US · est. 2013

Lyric, a clinical-stage company, innovates gastrointestinal therapeutics for unmet hospital needs.

Series A · $20.4M6
Cara TherapeuticsCara TherapeuticsStamford, CT, USDrugs, Therapeuticsest. 2004Cara TherapeuticsStamford, CT, US · est. 2004

Cara Therapeutics, a Connecticut-based medical firm, develops novel drugs for pain and inflammation treatment.

Public · $517.2M106
Cyrano TherapeuticsCyrano TherapeuticsDelray Beach, FL, USPharmaceuticals, Therapeuticsest. 2014Cyrano TherapeuticsDelray Beach, FL, US · est. 2014

Cyrano Therapeutics: Innovating intranasal solutions to restore taste and smell functions.

Series B · $21.8M7
GelTex Pharmaceuticals
GelTex Pharmaceuticals
Acquired$6.8M01992Waltham, MA, US
Co-Founder

Leadership at GelTex Pharmaceuticals

Bob CarpenterBob CarpenterCo-Founder
JAMES BRUCE TANANBAUMJAMES BRUCE TANANBAUMCo-Founder

Similar to GelTex Pharmaceuticals

GlycologixGlycologixBeverly, MA, USBiomaterials, Therapiesest. 2016GlycologixBeverly, MA, US · est. 2016

Glycologix: A biotech firm specializing in R&D for soft tissue protection and repair.

Pre-Seed · $2.9M6
Tega TherapeuticsTega TherapeuticsLos Angeles, CA, USPharmaceuticalsest. 2014Tega TherapeuticsLos Angeles, CA, US · est. 2014

TEGA Therapeutics: A pharmaceutical leader in glycan science, enhancing lives with innovative treatments.

Public · $1.5M5
GelSana TherapeuticsGelSana TherapeuticsAurora, CO, USWound Careest. 2020GelSana TherapeuticsAurora, CO, US · est. 2020

GelSana Therapeutics: Innovating wound healing with advanced hydrogel products.

Seed · $4.2M5
Galmed PharmaceuticalsGalmed PharmaceuticalsTel Aviv, Tel Aviv District, ILPharmaceuticalsest. 2000Galmed PharmaceuticalsTel Aviv, Tel Aviv District, IL · est. 2000

Tel Aviv-based Galmed Pharmaceuticals develops and commercializes treatments for liver diseases and cholesterol gallstones.

Public · $103.6M24
Nano Terra
Nano Terra
Series A$26.4M302005Cambridge, MA, US
Board Member· Board

Leadership at Nano Terra

Myer BerlowMyer BerlowBoard Member
Ueli MorantUeli MorantFounder
Sindi HayatSindi HayatBoard Member
Soft Robotics
Soft Robotics
Series C$86M1342012Cambridge, MA, US
Board Member· Board

Leadership at Soft Robotics

Jeffrey A BeckJeffrey A BeckBoard Member
Adam SharkawyAdam SharkawyBoard Member
Kevin DunlapKevin DunlapBoard Member
Carmichael RobertsCarmichael RobertsBoard Member
MC10
MC10
Series A$97.4M382008Cambridge, MA, US
Co-Founder

Leadership at MC10

Roozbeh GhaffariRoozbeh GhaffariCo-Founder
Gilman CallsenGilman CallsenCo-Founder
Paul H. KlingensteinPaul H. KlingensteinBoard Member
Adam FineAdam FineBoard Member
Jiong MaJiong MaBoard Member
John RogersJohn RogersCo-Founder

George Whitesides's Co-Investors

Dennis BennieDennis BennieCo-invested · Validere SeedT. Chen FongT. Chen FongCo-invested · Validere SeedShahram TafazoliShahram TafazoliCo-invested · Validere SeedLisa ShieldsLisa ShieldsCo-invested · Validere SeedPaul BuchheitPaul BuchheitCo-invested · Validere SeedAli RowghaniAli RowghaniCo-invested · Validere SeedElizabeth IornsElizabeth IornsCo-invested · Validere Seed

George Whitesides's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to George Whitesides

Juan EnriquezJuan EnriquezFounder & CEO · BiotechonomyBrian P McVeighBrian P McVeighBoard Member · GenisphereWilliam P WiesmannWilliam P WiesmannBoard Member · SynspiraKenneth KelleyKenneth KelleyBoard Member · SeromYx SystemsWim Van CriekingeWim Van CriekingeCo-Founder · Novalis BiotechKyle ChenetKyle ChenetFounder · LQ3 Pharmaceuticals